Airway Therapeutics, Inc.

This study is testing if an investigational drug called Zelpultide Alfa can prevent a serious lung condition called bronchopulmonary dysplasia (BPD) in extremely premature babies. The trial will enroll 366 babies born very early (between 22 and 28 weeks) who are on a breathing ma…